These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 16446404)

  • 21. Cytoplasmic/nuclear shuttling and tumor progression.
    Wang SC; Hung MC
    Ann N Y Acad Sci; 2005 Nov; 1059():11-5. PubMed ID: 16382038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of heregulins and associations with the ErbB family of tyrosine kinase receptors in papillary thyroid carcinomas.
    Fluge O; Akslen LA; Haugen DR; Varhaug JE; Lillehaug JR
    Int J Cancer; 2000 Sep; 87(6):763-70. PubMed ID: 10956383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast growth factor 3, a protein with a dual subcellular fate, is interacting with human ribosomal protein S2.
    Antoine M; Reimers K; Wirz W; Gressner AM; Müller R; Kiefer P
    Biochem Biophys Res Commun; 2005 Dec; 338(2):1248-55. PubMed ID: 16263090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of heregulin in human cancer.
    Breuleux M
    Cell Mol Life Sci; 2007 Sep; 64(18):2358-77. PubMed ID: 17530167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear translocation of cell-surface receptors: lessons from fibroblast growth factor.
    Bryant DM; Stow JL
    Traffic; 2005 Oct; 6(10):947-54. PubMed ID: 16138907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain.
    Sardi SP; Murtie J; Koirala S; Patten BA; Corfas G
    Cell; 2006 Oct; 127(1):185-97. PubMed ID: 17018285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of nuclear translocation of insulin.
    Harada S; Smith RM; Jarett L
    Cell Biochem Biophys; 1999; 31(3):307-19. PubMed ID: 10736753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies differentiate desmosome-form and nucleus-form pinin: evidence that pinin is a moonlighting protein with dual location at the desmosome and within the nucleus.
    Ouyang P
    Biochem Biophys Res Commun; 1999 Sep; 263(1):192-200. PubMed ID: 10486276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ErbB-4 s80 intracellular domain is a constitutively active tyrosine kinase.
    Linggi B; Cheng QC; Rao AR; Carpenter G
    Oncogene; 2006 Jan; 25(1):160-3. PubMed ID: 16170367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of heregulin symmetry by weighted evolutionary tracing.
    Landgraf R; Fischer D; Eisenberg D
    Protein Eng; 1999 Nov; 12(11):943-51. PubMed ID: 10585499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-erbB-3: a nuclear protein in mammary epithelial cells.
    Offterdinger M; Schöfer C; Weipoltshammer K; Grunt TW
    J Cell Biol; 2002 Jun; 157(6):929-39. PubMed ID: 12045181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ErbB-4 s80 intracellular domain abrogates ETO2-dependent transcriptional repression.
    Linggi B; Carpenter G
    J Biol Chem; 2006 Sep; 281(35):25373-80. PubMed ID: 16815842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heregulin promotes expression and subcellular redistribution of ADP-ribosylation factor 3.
    Li F; Mandal M; Mishra SK; Barnes CJ; Kumar R
    FEBS Lett; 2002 Jul; 524(1-3):49-53. PubMed ID: 12135740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear trafficking of secreted factors and cell-surface receptors: new pathways to regulate cell proliferation and differentiation, and involvement in cancers.
    Planque N
    Cell Commun Signal; 2006 Oct; 4():7. PubMed ID: 17049074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer.
    Mota JM; Collier KA; Barros Costa RL; Taxter T; Kalyan A; Leite CA; Chae YK; Giles FJ; Carneiro BA
    Oncotarget; 2017 Oct; 8(51):89284-89306. PubMed ID: 29179520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NRG1 fusions in breast cancer.
    Howarth KD; Mirza T; Cooke SL; Chin SF; Pole JC; Turro E; Eldridge MD; Garcia RM; Rueda OM; Boursnell C; Abraham JE; Caldas C; Edwards PAW
    Breast Cancer Res; 2021 Jan; 23(1):3. PubMed ID: 33413557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuregulin1 acts as a suppressor in human lung adenocarcinoma via AKT and ERK1/2 pathway.
    Wang Y; Ning Z; Zhou X; Yang Z; Tang H; Xu M; Wang X; Zhao J; Bai Y
    J Thorac Dis; 2018 Jun; 10(6):3166-3179. PubMed ID: 30069312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heregulin, a new interactor of the telosome/shelterin complex in human telomeres.
    Menendez JA; Benboudjema L; Vellon L; Rubio MA; Espinoza I; Campisi J; Lupu R
    Oncotarget; 2015 Nov; 6(37):39408-21. PubMed ID: 26327598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heregulin, a new regulator of telomere length in human cells.
    Menendez JA; Rubio MA; Campisi J; Lupu R
    Oncotarget; 2015 Nov; 6(37):39422-36. PubMed ID: 26318724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance.
    Cordo Russo RI; Béguelin W; Díaz Flaqué MC; Proietti CJ; Venturutti L; Galigniana N; Tkach M; Guzmán P; Roa JC; O'Brien NA; Charreau EH; Schillaci R; Elizalde PV
    Oncogene; 2015 Jun; 34(26):3413-28. PubMed ID: 25174405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.